Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Marin

Showing results (101-110 of 180) with videos related to

Pageof 18
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2024
Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic SyndromeOren Pasvolsky, Rima M Saliba, Uday R Popat, et al.
Blood|June 4, 2020
Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALLNeeraj Saini, David Marin, Celina Ledesma, et al.
Blood Advances|January 24, 2025
TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantationKonstantinos Lontos, Rima M Saliba, Rashmi Kanagal-Shamanna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2017
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic TransplantationMaria R Khouri, Elias J Jabbour, Alison M Gulbis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinibDavid Marin, Alexandra Bazeos, Francois-Xavier Mahon, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 25, 2024
Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid LeukemiaJason Yeh, Oren Pasvolsky, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil RecoveryRohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
Haematologica|October 26, 2010
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised hostHugues de Lavallade, Paula Garland, Takuya Sekine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid LeukemiaMithun Vinod Shah, Jeffrey L Jorgensen, Rima M Saliba, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 1, 2020
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipientsAla Abudayyeh, Heather Lin, Maen Abdelrahim, et al.
Pageof 18

Showing results (101-110 of 180) with videos related to

Sort By:
Pageof 18
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2024
Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic SyndromeOren Pasvolsky, Rima M Saliba, Uday R Popat, et al.
Blood|June 4, 2020
Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALLNeeraj Saini, David Marin, Celina Ledesma, et al.
Blood Advances|January 24, 2025
TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantationKonstantinos Lontos, Rima M Saliba, Rashmi Kanagal-Shamanna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2017
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic TransplantationMaria R Khouri, Elias J Jabbour, Alison M Gulbis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinibDavid Marin, Alexandra Bazeos, Francois-Xavier Mahon, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 25, 2024
Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid LeukemiaJason Yeh, Oren Pasvolsky, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil RecoveryRohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
Haematologica|October 26, 2010
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised hostHugues de Lavallade, Paula Garland, Takuya Sekine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid LeukemiaMithun Vinod Shah, Jeffrey L Jorgensen, Rima M Saliba, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 1, 2020
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipientsAla Abudayyeh, Heather Lin, Maen Abdelrahim, et al.
Pageof 18